In partnership with

Plus: rescheduling replies Nov. 5, hemp's Nov. 12 clock, California's license split.
§
THE REGULATOR BRIEF
Issue 024 · November 2, 2026
Read on web →
Cream line drawing of a chain of links on deep navy, one link highlighted in pink beneath an official seal outline: the week's federal supply-chain deadline
Headlines this week
DEA registers 900+ medical dispensaries — supply chains due Nov. 29

For the first time, the federal government has registered state-licensed marijuana dispensaries under the Controlled Substances Act. The Justice Department said October 30 that DEA is issuing registrations to more than 900 medical dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia — the first phase of the April Schedule III order for state medical marijuana. The same day, DEA told every business that applied in the April–June window that it must trade only with other timely applicants or DEA registrants, and have that supply chain in place no later than November 29. Adult-use sales are not covered. Elsewhere: reply briefs on the GAO report close the rescheduling record track November 5, the first federal hemp clock runs out November 12, and California proposed permanent rules letting dual licensees split off their medical side to pursue DEA registration. Voters in Massachusetts, Idaho and Houston decide cannabis measures Tuesday; we will report results next week.

This week at a glance

Top story. DEA issued its first registrations to state-licensed medical dispensaries and set a November 29 deadline for every timely applicant to deal only with DEA-registered or timely-applicant counterparties.

Next three.

1.Rescheduling — GAO-report briefs were filed October 29; replies close November 5, and the stay expires with them.
2.Hemp — 10 days to the November 12 synthetics exclusion; Congress's researchers confirm FDA still has not published its required cannabinoid lists.
3.California — DCC proposed permanent rules to split combined A/M licenses; comments are due December 14.
What this means for you this week
•Medical operators that applied to DEA: audit every supplier and buyer now. From November 29, counterparties must be timely applicants or DEA registrants — verify their DEA control number or certificate and their active state license, and keep the records.
•Hemp sellers: products built on cannabinoids the plant cannot naturally produce lose federal hemp status November 12. The total-THC and container-cap changes wait until December 11.
•Illinois and New Jersey: Illinois manufacturer license applications are due before November 9; New Jersey's November 13 beverage cutoff is still the law.

Tell us: if you hold a state medical license, has a supplier or buyer of yours been left off DEA's timely-applicant list? Reply to this email. We read every reply, and the answers shape what we cover next.

Advertising opens in this issue — exclusive state, country & category placements from $75/mo. Details below, or skip ahead →
Federal & agency desk
DEA registers 900+ medical dispensaries in seven states; supply chains must close by Nov. 29

Why it matters: This is the first time state-licensed cannabis businesses hold federal registrations. It also sets a hard date: after November 29, a timely applicant that buys from or sells to a business outside the DEA system risks denial of its own application. Operators that did not file in the window cannot be supplied by those that did. Talk to your counsel about your counterparty list.

DOJ announced October 30 that DEA is issuing registrations to more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia — the first phase of carrying out the Attorney General's April order under 21 U.S.C. 811(d). Manufacturer and distributor applications remain under review, pending inspections, production controls and quota. “State licensure alone does not automatically grant federal registration,” the release says, and the order does not authorize adult-use activity.

DEA's companion letter defines timely applicants as businesses that filed complete applications between April 28 and June 26, 2026. They and registrants may deal in Schedule III medical marijuana only with each other, and must establish compliant supply chains no later than November 29. Minimum diligence: verify the counterparty's DEA document control number or certificate, confirm its state license is active, and keep records. Existing inventory may still be sold; a narrow exception covers small in-state lab samples. The letter says it does not have the force of law. DEA's posted applicant list carries no business names; Marijuana Moment's October 30 tally of it counted roughly 7,000 applicants.

Rescheduling: GAO-report briefs are in; the record track closes Nov. 5

Why it matters: When replies land November 5, the stay that froze the adult-use rescheduling case expires by its terms. No date is set for the judge's recommended decision, so 280E relief for adult-use operators is still unscheduled. Keep both tax scenarios open with your adviser.

Optional briefs on the GAO report (GAO-26-108623) were filed October 29 under Chief ALJ Julius's October 22 order in DEA Docket No. 1362. Per Marijuana Moment's October 30 reporting, DEA asked the judge to give the report “no weight,” while opponents argued it should weigh decisively against the proposal. Replies are due November 5. DEA's rescheduling docket page had not posted the briefs as of November 1.

Hemp countdown: 10 days to Nov. 12, and FDA's cannabinoid lists still are not out

Why it matters: The November 12 date reaches only products built on cannabinoids the plant cannot naturally produce. Everything else in the redefinition — total THC, the 0.4 mg container cap — waits until December 11. Sort SKUs by which date binds them now; no rescue bill moved this week.

A Congressional Research Service legal sidebar dated October 28 (LSB11496) confirms the split: the synthetics exclusion stays on the November 12 schedule, while most other amendments to the hemp definition were delayed to December 11 by P.L. 119-103. CRS also notes FDA “has not published any of these items” — the cannabinoid lists Congress required. Delay bills H.R. 7024, H.R. 7010 and S. 3686 and repeal bill H.R. 6209 remain pending. FDA's information-sharing database still lists eight state hemp agreements with an October 31 expiration and no renewal as of November 1.

Statehouse roundup
California proposes permanent rules to split dual licenses for DEA registration

Why it matters: California's combined adult-use/medical licensees cannot register federally while their medical and adult-use sides share one license. The proposal gives them a voluntary path to separate. With DEA's first registrations out, it is the state-level step that makes the federal one reachable. Comments close December 14.

DCC rulemaking DCC-2026-04-R would let a single license holding both A and M designations be reissued as separate medicinal and adult-use licenses through an expedited process, including to a different legal entity if conditions are met. The notice ties the change to the April 28 Schedule III order and estimates about 1,600 affected licensees, roughly 97% of them small businesses. Written comments are due December 14; a public hearing is set for December 15 at 10 a.m.

New Jersey: the Nov. 13 hemp-beverage cutoff still stands

Why it matters: Sellers should plan for November 13 until a bill is signed. S4635 would move the date to the federal compliance date, no earlier than December 11, but it still needs the Assembly and the governor with less than two weeks left.

S4635 would replace the fixed November 13, 2026 sales deadline for intoxicating hemp beverages with “the federal compliance date.” Its Assembly companion is A5604. We found no Assembly floor vote or signature through November 1. Our monitors flagged revisions to two New Jersey CRC pages on October 26; those are under review.

Illinois: manufacturer license applications due before Nov. 9

Why it matters: Current hemp manufacturers that miss the window face the Hemp Act's start date without a license. From November 12, hemp over the state's limits becomes cannabis, and products meant for smoking or vaping cannot be sold as hemp at any THC level.

The Illinois Department of Agriculture's bulletin sets the Hemp Product Manufacturer License at $5,000 and asks existing manufacturers to apply before November 9 so they can keep operating when the Hemp Act takes effect November 12.

New York: 50-slot nursery window opens Nov. 5

Why it matters: Only the first 50 applications will be considered, and later fees are returned. Applicants who need a nursery license for 2027 planting should be ready to file on day one.

OCM's notice sets a $1,000 nonrefundable application fee, license fees from $750 (outdoor) to $2,000 (indoor), and a 50% reduction for social and economic equity applicants. Nursery licensees may not hold interests in retail, delivery or on-site consumption licenses.

Oklahoma: HB 4454 processor rules now binding

Why it matters: As of November 1, dispensaries should not take in processor product that fails the HB 4454 requirements. Checking inventory on intake is cheaper than a stop-sale.

OMMA's HB 4454 clarification notice for processors and dispensaries bars transfers of non-compliant processor product from November 1.

Across the wires

Developments our desk is tracking that have not yet moved a record — proposed, pending or at the ballot box.

•November 3 ballots — Massachusetts Question 8 would repeal adult-use retail sales effective January 1, 2028; Idaho HJR 4 would reserve legalization to the legislature; Houston Proposition A would deprioritize misdemeanor possession. Records move with the results. MA · ID · Houston
•H.R. 10929 — a House bill would add a 50% duty on Chinese hemp-cannabinoid products and require import testing, per Marijuana Moment's October 30 reporting. Introduced only; no record change until enacted. MM →
•USPS — Sens. Lankford and Budd urged the Postal Service to keep its ban on mailing marijuana, per Marijuana Moment's October 29 reporting. A letter, not a rule; nothing moves. MM →
•Maryland — the Cannabis Administration sent a regulatory package (including product “sniff jars”) to the legislature's AELR committee, per the Marijuana Herald's October 30 reporting. Proposed; we move the record when the text is published. Herald →
International desk
UK: first CBD novel-food authorisations still await ministers

Why it matters: Until ministers act, UK CBD food products remain on the FSA's public list rather than authorised. Brands should keep their list status and dossiers current; the decision, not the board recommendation, changes the market.

The Food Standards Agency's recommendations to ministers on the first CBD novel-food authorisations, from its September board meeting, were last updated October 19. No ministerial decision was published through November 1.

A light week internationally: we checked Germany, the EU, Canada, Thailand, Czechia and Switzerland and found no primary-source change in the window.

The change log WK 10/27–11/1 · SIGNALS ONLY
Row of engraved document outlines on cream, one filled hot pink: the change-log monitoring motif
What our monitors caught

Every legality status on cannabisregulations.ai is a versioned record in our own database — built, sourced and refined over two-plus years. Our monitors watch statutes, registers and agency pages directly; when a document changes, a human reviews it before anything publishes.

No new record changes this week. The 22 corrections we reported last issue were the latest to publish. This week's work is in the review queue.

Detected · under review

Our monitors flagged these documents as changed. Nothing publishes to our records without human review — until then, here is what we can see.

UNDER REVIEW SIG-A401B221 · 11/01
Hungary · national statute page (njt.jog.gov.hu)
Our read: the consolidated text our Hungary records cite changed on November 1. We have not yet compared versions; a page change alone does not move a record.
UNDER REVIEW SIG-E69539AC · 10/30
Maryland · Cannabis Administration laws and regulations page (cannabis.maryland.gov)
Our read: the change lines up with reporting that the MCA sent a regulatory package to AELR on October 24. We will read the proposal itself before touching any Maryland record.
UNDER REVIEW SIG-6669EA00 · 10/30
Ohio · Administrative Code chapter 901:14 (codes.ohio.gov)
Our read: the chapter's page changed. We are checking whether any rule text was amended or only the page was republished.
UNDER REVIEW SIG-C9F332F8 · 10/29
Florida · OMMU rules and regulations page (knowthefactsmmj.com)
Our read: the medical-program rules page was revised. We are checking for new or amended rules before updating Florida records.

Twenty-five more flagged documents from the last ten days — including Arkansas, West Virginia, Minnesota, Idaho and Utah — are in the queue.

136
Active monitors
1,113
Versioned records
258
Jurisdictions

Every record carries its source, effective date and revision history. Human-reviewed before publishing. Built over two-plus years.

From our database
First complete state legality database
Every cannabinoid. Every state. One database.

Recreational, medical, THCA, Delta-8, Delta-9, HHC, CBD and more — across all 50 states, DC and Puerto Rico, with sources and effective dates on every record. The pages behind every link in this issue.

Open the state laws database →
Partner with us
Subscriber-only · limited slots
Own the page your buyers are already on.

The people reading this — cannabis attorneys, compliance officers, licensed operators across the US, EU, UK and Canada — are the same people searching our state and country legality pages every day: 7,500+ subscribers, 30,000+ monthly site visits. Every placement below is sold as an exclusive: one sponsor per state, one per category. When a slot is booked, it is gone until it lapses.

Presenting sponsor — this newsletter
Top-of-issue billing to 7,500+ regulators, operators & counsel
$450 /issue
Newsletter banner
In-issue placement, one advertiser per send
$325 /issue
State page exclusive
Sole sponsor of a state's legality pages — 50 states, one sponsor each
from $125 /mo
Country page exclusive
158 country pages, strong EU/UK/Canada readership
from $75 /mo
Directory category exclusive
Own your software category — POS, payments, seed-to-sale and more
from $199 /mo
Homepage placement
Site-wide visibility on cannabisregulations.ai
$350 /mo
Request placements →

These rates are currently offered to newsletter subscribers and early users only, ahead of the public media kit.

For attorneys & firms
Your firm may already be listed. Make it yours.

Our lawyer directory lists 575+ cannabis and hemp practices, searchable by state and practice area — the page prospective clients land on when they need counsel in your state. Claiming your listing is free. A paid listing adds:

✓Verified badge on your profile and in search results
✓Featured placement at the top of your state's results
✓Free-consultation flag that filters you into high-intent searches
✓Directory spotlight eligibility in future issues of this brief
Need help with anything in this brief?
Explore our SaaS business directory
Software & services for the industry — POS, payments, seed-to-sale, compliance and more, by category and state.
Browse the business directory →
Find counsel
575+ cannabis & hemp attorneys, by state and practice area.
Lawyer directory →
One thing to read

With November 12 ten days out, our guide to state hemp deadlines sets out which state dates bind before the federal December 11 delay — Missouri and Illinois on November 12, plus Virginia, Ohio and Texas rules already in force — and why each product should be planned around the earliest date that applies to it. Read the summary →

Stop losing deals in between meetings.

Aligned is changing how B2B teams run their most important deals.

Most reps guess where a deal really stands. They forecast on a gut feeling and the buyer’s word vs what's actually happening. Then they realize the deal slipped through only after it's too late. Aligned surfaces what buyers are actually doing inside every deal: the risks, the openings, and the exact next step to keep things moving.

Start increasing your close rates and stand up your first deal room in minutes.

Reach the people who write the compliance checks.

The Regulator Brief goes out every Monday to cannabis attorneys, compliance officers, and licensed operators across US states and international jurisdictions. If you want to put your product in front of them, get in touch.

Know someone who'd benefit from this?

Forward it, or use your personal link below. Refer three colleagues and we'll send you our 50-state cannabis legality reference PDF.